ticlopidine has been researched along with Necrobiosis Lipoidica in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Necrobiosis Lipoidica: A degenerative disease of the dermal connective tissue characterized by the development of erythematous papules or nodules in the pretibial area. The papules form plaques covered with telangiectatic vessels. More than half of the affected patients have diabetes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnetblanc, JM | 1 |
| Julia, A | 1 |
| Rigaud, M | 1 |
| Rhodes, EL | 1 |
2 other studies available for ticlopidine and Necrobiosis Lipoidica
| Article | Year |
|---|---|
Antithrombotic agents in necrobiosis lipoidica.
Topics: Adolescent; Adult; Diabetes Complications; Female; Fibrinolytic Agents; Humans; Necrobiosis Lipoidic | 1986 |
Necrobiosis lipoidica treated with ticlopidine.
Topics: Humans; Necrobiosis Lipoidica; Ticlopidine | 1986 |